Literature DB >> 10220555

Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ullrich-Scheie syndrome).

T A Fischer1, H A Lehr, U Nixdorff, J Meyer.   

Abstract

The genetic mucopolysaccharidosis syndromes (MPS) are autosomal recessive inborn errors of metabolism. Heart valve involvement in MPS is not uncommon but only a few case reports of successful cardiac surgery are available. In particular, reports of combined aortic and mitral stenosis associated with MPS type I-S are very rare. Both type I and type VI MPS are associated with significant left sided valvar heart disease that requires surgical valve replacement because of irregular valve thickening, fibrosis, and calcification. A 35 year old man had severe mitral valve stenosis after successful surgical replacement of a stenotic aortic valve. Valvar heart disease was investigated by cardiac ultrasound and left heart catheterisation. Histomorphological characterisation of the affected mitral valve was performed. The case illustrates typically associated clinical features of cardiac and extracardiac abnormalities found in MPS type I-S.

Entities:  

Mesh:

Year:  1999        PMID: 10220555      PMCID: PMC1728901          DOI: 10.1136/hrt.81.1.97

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

Review 1.  Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.

Authors:  J E Wraith
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

2.  Cardiac manifestations in the mouse model of mucopolysaccharidosis I.

Authors:  Maria C Jordan; Yi Zheng; Sergey Ryazantsev; Nora Rozengurt; Kenneth P Roos; Elizabeth F Neufeld
Journal:  Mol Genet Metab       Date:  2005-06-24       Impact factor: 4.797

Review 3.  Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.

Authors:  Barbara A Rosser; Calvin Chan; Andreas Hoschtitzky
Journal:  Biomedicines       Date:  2022-02-04

4.  Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation.

Authors:  A J T Schuldt; T J Hampton; V Chu; C A Vogler; N Galvin; M D Lessard; J E Barker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

Review 5.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

6.  Combined Aortic and Mitral Valve Stenosis in Mucopolysaccharidosis Syndrome Type I-S: A Report of a Rare Case.

Authors:  Hakimeh Sadeghian; Afsaneh Sadeghian; Bahareh Eslami; Seyed Hesameddin Abbasi; Masoumeh Lotfi-Tokaldany
Journal:  J Tehran Heart Cent       Date:  2021-01

Review 7.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04

8.  Heart valve disease in Hurler-Scheie syndrome.

Authors:  María Del Carmen García Del Rey; Javier Castrodeza; Ángel Pinto; Maria Ángeles Espinosa Castro; Cecilia Muñoz Delgado; Francisco Fernández-Avilés
Journal:  Cardiol J       Date:  2022-07-12       Impact factor: 3.487

9.  Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

Authors:  O I I Soliman; R G M Timmermans; A Nemes; W B Vletter; J H P Wilson; F J ten Cate; M L Geleijnse
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.